IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts - PubMed (original) (raw)
IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts
C Doucet et al. Int Immunol. 1998 Oct.
Abstract
Subepithelial fibrosis in the bronchi of asthmatics is the result of an irreversible lung fibroblast activation, triggered by cytokines secreted by IL-4- and IL-5-activated inflammatory cells. Here, we provide evidence that human lung fibroblasts (ICIG7 cells) express a single class of high-affinity IL-4 receptor (IL-4R). This receptor is functional and composed of at least the IL-4Ralpha and IL-13Ralpha1 chains in the absence of the IL-2Rgamma chain. The IL-4Ralpha is efficiently internalized at 37 degrees C within 15 min in the presence of IL-4, whereas this process is slower with IL-13. In ICIG7 cells, IL-4 triggers the tyrosine phosphorylation of at least two proteins (110 and 180 kDa), and up-regulates the transcription of c-fos, c-jun and c-myc proto-oncogenes. In addition, the secretion of several cytokines [IL-6, granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor (GM-CSF)] as well as the expression of beta1 integrin and VCAM-1 adhesion molecules are augmented by IL-4. IL-13 displays similar biological activities, but less effectively than IL-4. On the other hand, ICIG7 cells could constitute a lung fibroblast population defined by the spontaneous release of several pro-inflammatory cytokines (IL-6, IL-11 and GM-CSF) and cell surface phenotype (CD4 and Thy-1). Through this peculiar cytokine pattern and the IL-4/IL-13-dependent activities, these cells could act as effector cells in the pathogenesis of asthma, triggering and maintaining the recruitment, homing and activation of bone marrow-derived inflammatory cells, and playing a role in the remodeling process of the airways.
Similar articles
- Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.
Doucet C, Brouty-Boyé D, Pottin-Clémenceau C, Canonica GW, Jasmin C, Azzarone B. Doucet C, et al. J Clin Invest. 1998 May 15;101(10):2129-39. doi: 10.1172/JCI741. J Clin Invest. 1998. PMID: 9593769 Free PMC article. - Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C, Giron-Michel J, Canonica GW, Azzarone B. Doucet C, et al. Eur J Immunol. 2002 Sep;32(9):2437-49. doi: 10.1002/1521-4141(200209)32:9<2437::AID-IMMU2437>3.0.CO;2-N. Eur J Immunol. 2002. PMID: 12207328 - Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.
Murata T, Husain SR, Mohri H, Puri RK. Murata T, et al. Int Immunol. 1998 Aug;10(8):1103-10. doi: 10.1093/intimm/10.8.1103. Int Immunol. 1998. PMID: 9723696 - Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis.
Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM. Jakubzick C, et al. Immunol Res. 2004;30(3):339-49. doi: 10.1385/IR:30:3:339. Immunol Res. 2004. PMID: 15531774 Review. - Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.
Song X, Traub B, Shi J, Kornmann M. Song X, et al. Int J Mol Sci. 2021 Jan 13;22(2):727. doi: 10.3390/ijms22020727. Int J Mol Sci. 2021. PMID: 33450900 Free PMC article. Review.
Cited by
- Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets.
Hansi RK, Ranjbar M, Whetstone CE, Gauvreau GM. Hansi RK, et al. Biomedicines. 2024 Oct 11;12(10):2312. doi: 10.3390/biomedicines12102312. Biomedicines. 2024. PMID: 39457624 Free PMC article. Review. - Cell line-based in vitro models of normal and chronic bronchitis-like airway mucosa to study the toxic potential of aerosolized palladium nanoparticles.
Ji J, Jansen K, Kessler V, Seisenbaeva G, Gerde P, Malmlöf M, Palmberg L, Upadhyay S. Ji J, et al. Front Med (Lausanne). 2024 Oct 8;11:1422792. doi: 10.3389/fmed.2024.1422792. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39440037 Free PMC article. - Retinal Vascular Abnormalities and Clinical Parameters in Systemic Sclerosis.
Foti R, Zeppieri M, Foti R, Visalli E, Amato G, Amato R, Dammino E, D'Esposito F, Gagliano C. Foti R, et al. J Clin Med. 2024 May 7;13(10):2738. doi: 10.3390/jcm13102738. J Clin Med. 2024. PMID: 38792282 Free PMC article. - The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis.
Bobeica C, Niculet E, Musat CL, Iancu L, Craescu M, Luca AM, Stefanescu BI, Gheorghe E, Debita M, Vasile CI, Balan G, Busila C, Tatu AL. Bobeica C, et al. Clin Cosmet Investig Dermatol. 2024 Jan 26;17:211-218. doi: 10.2147/CCID.S432422. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38292323 Free PMC article. - Development of Adaptive Immunity and Its Role in Lung Remodeling.
Esnault S, Jarjour NN. Esnault S, et al. Adv Exp Med Biol. 2023;1426:287-351. doi: 10.1007/978-3-031-32259-4_14. Adv Exp Med Biol. 2023. PMID: 37464127
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous